Tumor inhibitors. I. Preliminary investigation of antitumor activity of Sarracenia flava.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000302:isolation & purification* / Q000627:therapeutic use; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005845:Georgia; D006801:Humans; D007273:Injections, Intramuscular; D007939:Leukemia L1210 / Q000188:drug therapy; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D051379:Mice; D008815:Mice, Inbred Strains; D009062:Mouth Neoplasms / Q000188:drug therapy; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy*; D010936:Plant Extracts / Q000302:isolation & purification / Q000627:therapeutic use; D010946:Plants, Medicinal / Q000032:analysis*; D051381:Rats; D013055:Spectrophotometry, Infrared; D014315:Triterpenes / Q000008:administration & dosage / Q000302:isolation & purification* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D010936:Plant Extracts; D014315:Triterpenes